Lineage Cell Therapeutics In shares owned by Ing Investment Management
Quarter-by-quarter ownership of Lineage Cell Therapeutics In (LCTX) shares owned by Ing Investment Management
from 13F filings
Historical chart of Ing Investment Management investment in Lineage Cell Therapeutics In
Tip: Access up to 7 years of quarterly data
All positions including Lineage Cell Therapeutics In held by Ing Investment Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Lineage Cell Therapeutics In by Ing Investment Management
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2026-06-30 | $49k | 37k | 1.31 |
| 2025-03-31 | $18k | 39k | 0.45 |
| 2024-12-31 | $20k | 39k | 0.50 |
| 2024-09-30 | $51k | 57k | 0.91 |
| 2024-06-30 | $57k | 57k | 1.00 |
| 2024-03-31 | $71k | 48k | 1.48 |
| 2023-12-31 | $62k | 57k | 1.09 |
| 2023-09-30 | $67k | 57k | 1.18 |
| 2023-06-30 | $80k | 57k | 1.41 |
| 2022-03-31 | $73k | 47k | 1.54 |
| 2021-12-31 | $116k | 47k | 2.45 |
| 2021-09-30 | $121k | 48k | 2.52 |
| 2021-06-30 | $137k | 48k | 2.86 |
| 2020-03-31 | $49k | 59k | 0.83 |
| 2019-12-31 | $64k | 72k | 0.89 |
| 2019-09-30 | $45k | 46k | 0.97 |